Antiplatelet therapy
Antiplatelet Therapy in Breast Cancer Patients Using Hormonal Therapy: Myths, Evidence and Potentialities – Systematic Review
... Tamoxifen therapy resulted in increased VEGF concentrations in platelets, but no change in plasma VEGF ...that antiplatelet therapy may interfere with angiogenic protein levels in women treated with ...
8
Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.
... that antiplatelet therapy had no significant difference in ischemic stroke risk to warfarin, whilst combination therapy was associated with higher ...combination therapy con- ferred a higher ...
13
Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy
... of therapy (T) and ...following therapy with simvastatin/ezetimibe seems restricted to lipid changes and improvement of endothelial function not affecting the release of microparticles, mobilization of ...
6
Platelet turnover in stable coronary artery disease - influence of thrombopoietin and low-grade inflammation.
... All diabetic patients were diagnosed with type 2 diabetes and treated with oral antidiabetic drugs and/or insulin. All non- diabetic patients had fasting plasma glucose levels ,7.0 mmol/L at the time of inclusion. ...
7
Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
... In patients without prior CVD (primary prevention), indica- tion for antiplatelet therapy remains unclear [13]. In this popu- lation, aspirin, the only antithrombotic drug studied in a sui- ciently large ...
19
Long Term Cardiovascular Outcome Based on Aspirin and Clopidogrel Responsiveness Status in Young ST‑Elevated Myocardial Infarction Patients
... different antiplatelet medications, many questions remain ...dual therapy is an essential predictor of MACE, including CV mortality and TVR in a three-year follow-up period in young patients undergoing ...
9
Resistência ao clopidogrel: prevalência e variáveis associadas.
... dual antiplatelet therapy with acetylsalicylic acid (ASA) and clopidogrel is the cornerstone of treatment for patients undergoing angioplasty with coronary stent ...
7
Int. J. Cardiovasc. Sci. vol.30 número5
... context, antiplatelet therapy occupies a prominent role in the management of pathologies arising from this process, notably acute coronary ...current therapy, demanding a complete knowledge of the ...
10
Braz. J. Pharm. Sci. vol.46 número3
... Several antiplatelet drugs have been developed to inhibit platelet activity in acute thrombotic situations as well as to prevent adverse ...events. Antiplatelet therapy is one of the most effective ...
5
Delphi-consensus weights for ischemic and bleeding events to be included in a composite outcome for RCTs in thrombosis prevention.
... aspirin therapy versus placebo (stopping anti platelet therapy) in the perioperative period in patients treated with antiplatelet therapy as secondary prevention (with documented symptomatic ...
6
Arq. Bras. Cardiol. vol.93 número2 en v93n2a20
... The COURAGE trial is an example of clinical trial often missing in the current clinical scenario - the comparative effectiveness studies - and the results were stunning. The primary endpoint was all-cause mortality and ...
4
Evaluation of platelet activity by multiple electrode impedance aggregometry in acute coronary syndromes: pilot study in a Brazilian tertiary-care public hospital
... Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the ...
5
Factors Associated with Inadequate Management of Antiplatelet Agents in Perioperative Period of Non-Cardiac Surgeries
... of antiplatelet therapy was rendered by the very patients, or by their companions, who in some situations said that opinions diverged between surgeon and cardiologist, or between surgeon and anesthetist, ...
9
Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1.
... In a cardiovascular risk population on aspirin mono antiplatelet therapy, we investigated the association between on-aspirin platelet aggregation and 15 SNPs in platelet-related genetic [r] ...
10
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, Brazil
... Antiplatelet therapy significantly reduces mortality in ...on antiplatelet therapy require cardiac surgery, as this represents a rec- ognized risk for increased surgical blood ...reversible ...
25
Rev. Bras. Cardiol. Invasiva vol.22 número3
... dual antiplatelet therapy for 3 or 12 months after zotarolimus eluting stent ...dual antiplatelet therapy) for net adverse clinical and cerebral events ...dual antiplatelet ...
7
Postoperative Bleeding Following Preoperative Clopidogrel Administration in Patients with Haemoglobin Level Above 110 gL Undergoing Urgent CABG
... dual antiplatelet therapy (DAPT) (usually clopidogrel + aspirin) prior to coronary catheterization, and approximately 10% of these patients require coronary artery bypass grafting ...
5
Anticoagulants and antiplatelet drugs during cataract surgery
... 2. Caligaris LS, Medina NH, Lansingh VC, Waldman EA, Yaacov-Pena F. Analyses of cataract surgery performed by the Unified Health System in Brazil, 2006-2007. Rev Panam Salud Publica. 2011;29(6):428-32. 3. Grzybowski A, ...
6
Braz. J. Cardiovasc. Surg. vol.28 número3
... In our study, the number of cerebral events in the ASA group was almost double that in patient with no antiplatelet therapy in the irst 30 days, without statically signiicance. This absolute difference can ...
6
Rev. bras. ter. intensiva vol.24 número3 en v24n3a13
... antiplatelet therapy, after percutaneous intervention, appear suitable as a guide for evaluating patients with NSTE ...without antiplatelet agents does not appear to increase the risk of ischemic ...
10